Scientific file / structure

Structure name:

MAAT PHARMA

Address:

317 avenue Jean Jaurès
69007 Lyon
France

https://www.maatpharma.com/
contact@maat-pharma.com

Area of intervention:

Antibiotics and alternative therapies, Sampling - detection and diagnosis, Microorganisms and host interactions/response, Bacterial strains
Therapeutic alternatives, Bacteriophage and phagotherapy, Drug delivery, Drug development, Gram negative, Gram positive, Host-microbiota interactions, Microbiome - microbiota and ecology, Synthesis - scale-up - production

Unity;

/

Team name:

/

Responsible:
(Unit director / head of structure)

AFFAGARD Hervé (CEO)

Type of structure:

Biotech

Region:

/

City:

Lyon

Description:​

Eligo is developing a new class of targeted biotherapeutic agents to selectively intervene on the microbiome.
Methods used : synthetic biology, protein and genome engineering to create Eligobiotics (genetic circuits packaged in phage-based delivery vectors) for diagnosis, eradication, or to functionalize targeted microbial populations.